细胞外囊泡重塑瘤环境用于癌症免疫疗法
Ming Yue1,2, Shengyun Hu1, Haifeng Sun1
1Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
Molecular cancer
|December 13, 2023
概括
细胞外囊泡 (EVs) 重塑瘤微环境 (TME),影响癌症免疫治疗的有效性. 了解EV角色和设计它们为改善抗瘤疗法和克服治疗挑战提供了新的策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 瘤免疫疗法已经推进了癌症治疗,但面临着诸如低响应率等挑战.
- 细胞外囊泡 (EVs),包括外体,越来越多地被认为是它们在病理条件中的作用.
- 瘤微环境 (TME) 中变化的EVs促进免疫抑制,影响免疫治疗的疗效.
研究的目的:
- 提供细胞外囊泡 (EV) 起源,生成和瘤微环境 (TME) 中的功能的全面概述.
- 讨论EVs在瘤发生过程中重塑TME的作用及其对免疫细胞表型的影响.
- 总结目前用于癌症免疫治疗的工程电动汽车的应用和进展,以及临床翻译的挑战.
主要方法:
- 对癌症中的细胞外囊泡 (EVs) 现有文献的审查和综合.
- 分析EV组件 (例如PD-1,非编码RNA) 和它们对TME内的免疫细胞的影响.
- 探索EV在抗瘤疗法和工程EV策略中的应用.
主要成果:
- 电动汽车在重塑免疫抑制性TME方面发挥着至关重要的作用.
- 特定的EV货物,如PD-1和非编码RNA,影响免疫细胞表型.
- 工程电动汽车在增强癌症免疫疗法方面表现有前途.
结论:
- 更深入地了解EV-TME相互作用对于识别治疗漏洞至关重要.
- 利用EV可能会提高现有的癌症免疫疗法的疗效.
- 解决临床翻译方面的挑战是推动基于EV的癌症治疗的关键.
关键词:
癌症免疫疗法癌症免疫疗法工程造型电动汽车 (EVs) 是指工程造型电动汽车.细胞外囊泡中的细胞外囊泡.淋巴结的微环境 淋巴结的微环境没有编码的RNA.在PD-1中使用PD-1.瘤微环境是一个微环境.更多相关视频
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10.2K
10:09Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
Published on: June 2, 2020
6.9K
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Cancer Vaccines
376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
